Skip to main content
. 2006 Jul 19;2006(3):CD003597. doi: 10.1002/14651858.CD003597.pub2

Richard 2000.

Methods Randomised, double‐blind 
 Multicentre study
Participants Number: 594 women 
 Age: 18‐55 years 
 Inclusion criteria: symptomatic UAC
Interventions GROUP 1 
 3 days oral rufloxacin (250 mg once daily)
GROUP 2 
 3 days oral pefloxacin (200 mg twice daily)
Outcomes Bacteriological and clinical response 
 Adverse events
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Low risk A ‐ Adequate